Erlotinib Completed Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01284335A Safety Study in Patients With Advanced Solid Tumors
NCT00603356Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
NCT01472016Study of ABT-700 in Subjects With Advanced Solid Tumors
NCT00139620A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function
NCT00739453A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)